Genetic variations and plasma levels of gelatinase A (matrix metalloproteinase-2) and gelatinase B (matrix metalloproteinase-9) in proliferative diabetic retinopathy

Molecular Vision

Volumn 14, Issue , 2008, Pages 1114-1121

  Beránek, Michal ^a   Kolar, Petr ^b   Tschoplova, Svatava ^a   Kankova, Katerina ^a   Vasku, Anna ^a  

^a MASARYK UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL BRNO   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ENDONUCLEASE; GELATINASE A; GELATINASE B;

ADULT; AGED; ALLELE; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DIABETIC RETINOPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; DIABETIC RETINOPATHY; DISEASE PROGRESSION; FEMALE; HAPLOTYPES; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; SEX CHARACTERISTICS; VARIATION (GENETICS);

EID: 45449114005     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Kohner EM. Diabetic retinopathy. BMJ 1993; 307:1195-9.
2. Abu El-AsrarAMVan den SteenPEAl-AmroSAMissottenLOpdenakkerGGeboesKExpression of angiogenic and fibrogenic factors in proliferative vitreoretinal disorders.Int Ophthalmol2007271122Epub 2007 Mar 21
3. Forrester JV, Shafiee A, Schroder S, Knott R, McIntosh L. The role of growth factors in proliferative diabetic retinopathy. Eye 1993; 7:276-87.
4. Cruickshanks KJ, Vadheim CM, Moss SE, Roth MP, Riley WJ, Maclaren NK, Langfield D, Sparkes RS, Klein R, Rotter JI. Genetic marker associations with proliferative retinopathy in persons diagnosed with diabetes before 30 yr of age. Diabetes 1992; 41:879-85.
5. Hiscott P, Waller HA, Grierson I, Butler MG, Scott DL. The extracellular matrix of reparative tissue in the vitreous: fibronectin production in proliferative diabetic retinopathy membranes. Eye 1993; 7:288-92.
6. Khokha R, Denhart DT. Matrix metalloproteinases and tissue inhibitor of metalloproteinases: a review of their role in tumorigenesis and tissue invasion. Invasion Metastasis 1989; 9:391-405.
7. Taylor CM, Thompson JM, Weiss JB. Matrix integrity and the control of angiogenesis. Int J Radiat Biol 1991; 60:61-4.
8. Furness PN. Basement membrane synthesis and degradation. J Pathol 1997; 183:1-3.
9. GolubnitschajaOJakscheAMoenkemannHYeghiazaryanKKarl SETrogDSchildHHLöfflerKUMolecular imaging system for possible prediction of active retinopathy in patients with Diabetes mellitus.Amino Acids20052822937Epub 2005 Feb 23
10. Grant MB, Caballero S, Tarnuzzer RW, Bass KE, Ljubimov AV, Spoerri PE, Galardy RE. Matrix metalloproteinase expression in human retinal microvascular cells. Diabetes 1998; 47:1311-7.
11. QiJHEbrahemQYeowKEdwardsDRFoxPLAnand-ApteBExpression of Sorsby's fundus dystrophy mutations in human retinal pigment epithelial cells reduces matrix metalloproteinase inhibition and may promote angiogenesis.J Biol Chem200227713394400Epub 2002 Jan 30
12. Salzmann J, Limb GA, Khaw PT, Gregor ZJ, Webster L, Chignell AH, Charteris DG. Matrix metalloproteinases and their natural inhibitors in fibrovascular membranes of proliferative diabetic retinopathy. Br J Ophthalmol 2000; 84:1091-6.
13. Ferrand PE, Parry S, Sammel M, Macones GA, Kuivaniemi H, Romero R, Strauss JF. A polymorphism in the matrix metalloproteinase-9 promoter is associated with increased risk of preterm premature rupture of membranes in African Americans. Mol Hum Reprod 2002; 8:494-501.
14. PriceSJGreavesDRWatkinsHIdentification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation.J Biol Chem2001276754958Epub 2000 Dec 12
15. Vasku A, Goldbergova M, Izakovicova Holla L, Siskova L, Groch L, Beranek M, Tschoplova S, Znojil V, Vacha J. A haplotype constituted of four MMP-2 promoter polymorphisms (-1575G/A, -1306C/T, -790T/G and -735C/T) is associated with coronary triple-vessel disease. Matrix Biol 2004; 22:585-91.
16. Zhang B, Henney A, Eriksson P, Hamsten A, Watkins H, Ye S. Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2-13.1. Hum Genet 1999; 105:418-23.
17. Zhang B, Herrmann SM, Eriksson P, de Maat M, Evans A, Arveiler D, Luc G, Cambien F, Hamsten A, Watkins H, Henney AM. Functional polymorphism in the regulatory region of gelatinase B gene in relation severity of coronary atherosclerosis. Circulation 1999; 99:1788-94.
18. Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs-an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology 1991; 98:786-806.
19. StephensMSmithNJDonnellyPA new statistical method for haplotype reconstruction from population data. Comment in: Am J Hum Genet. 2001 Oct;69(4):906-14.Am J Hum Genet20016897889Epub 2001 Mar 9
20. Kon CH, Occleston NL, Charteris D, Daniels J, Aylward GW, Khaw PT. A prospective study of matrix metalloproteinases in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 1998; 39:1524-9.
21. Lamblin N, Bauters G, Hermant X, Lablanche JM, Helbecque A, Amouyel P. Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery disease. J Am Coll Cardiol 2002; 40:43-8.
22. Koh KK, Ahn JY, Kang MH, Kim DS, Jin DK, Sohn MS, Park GS, Choi IS, Shin EK. Effects of hormone replacement therapy on plaque stability, inflammation, and fibrinolysis in hypertensive or overweight postmenopausal women. Am J Cardiol 2001; 88:1423-6.
23. Vegeto E, Bonincontro C, Pollio G, Sala A, Viappiani S, Nardi F, Brusadelli A, Viviani B, Ciana P, Maggi A. Estrogen prevents the lipopolysaccharide-induced inflammatory response in microglia. J Neurosci 2001; 21:1809-18.
24. Beranek M, Kankova K, Benes P, Izakovicova Holla L, Znojil V, Hajek D, Vlkova E, Vacha J. Polymorphism R25P in the gene encoding transforming growth factor-beta (TGF-beta1) is a newly identified risk factor for proliferative diabetic retinopathy. Am J Med Genet 2002; 109:278-83.
25. Brown D, Hamdi H, Bahri S, Kenney MC. Characterization of an endogeneus metalloproteinase in human vitreous. Curr Eye Res 1994; 13:639-47.
26. Das A, McGuire PG, Eriqat C, Ober RR, DeJuan E Jr, Williams GA, McLamore A, Biswas J, Johnson DW. Human diabetic neovascular membranes contain high levels of urokinase and metalloproteinase enzymes. Invest Ophthalmol Vis Sci 1999; 40:809-13.
27. De La Paz MA, Itoh Y, Toth CA, Nagase H. Matrix metalloproteinases and their inhibitors in human vitreous. Invest Ophthalmol Vis Sci 1998; 39:1256-60.
28. Jin M, Kashiwagi K, Iizuka Y, Tanaka Y, Imai M, Tsukahara, S. Matrix metalloproteinases in human diabetic and nondiabetic vitreous. Retina 2001; 21:28-33.
29. Kosano H, Okano T, Katsura Y, Noritake M, Kado S, Matsuoka T, Nishigori H. ProMMP-9 (92 kDa gelatinase) in vitreous fluid of patients with proliferative diabetic retinopathy. Life Sci 1999; 64:2307-15.
30. Harendza S, Lovett DH, Panzer U, Lukacs Z, Kuhnl P, Stahl RA. Linked common polymorphisms in the gelatinase a promoter are associated with diminished transcriptional response to estrogen and genetic fitness. J Biol Chem 2003; 278:20490-9.